/ Print /

Business Strategy

Opinion: More industry-stakeholders play blame game for high drug costsOur policy analyst weighs in on a new drug industry PR campaign that attempts to shift the blame for high drug costs.
Inaccurate provider directories create barriers to careHere are four ways that health plans can improve their internal processes for collecting provider data.
Five pharmacy regulations health execs must keep on their radars in 2017Here are five critical regulations that executives can begin to prepare for today.
What more transparency at the FDA means for health executivesResearchers create a set of recommendations for transparency at the agency in five principal areas.
Strategic planning amidst uncertainty: 10 considerations for health execsHealthcare leaders are concerned about developing reliable strategies for the future. Is effective strategic and financial planning even possible with so many variables up in the air?
Four ways Trump will shift digital healthcareWith ACA repeal and replace on the horizon, digital healthcare solutions will surely be affected.
GOP ACA replacement plan: 4 things health execs should knowWhat should managed care executives know about the GOP ACA replacement plan? Find out.
What providers need to do to improve chronic careA West survey finds that an overwhelming number of chronic care patients say they need help managing their disease.
More resources needed for medication-assisted treatmentInclude medication-assisted treatment high on the list of clinical tools used to treat opioid addiction.
ACA reform must preserve mental health pharmacy accessACA repeal or replacement must focus on how to preserve mental health services and pharmacy access.